Cargando…

Circulating tumour cells for early detection of clinically relevant cancer

Given that cancer mortality is usually a result of late diagnosis, efforts in the field of early detection are paramount to reducing cancer-related deaths and improving patient outcomes. Increasing evidence indicates that metastasis is an early event in patients with aggressive cancers, often occurr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lawrence, Rachel, Watters, Melissa, Davies, Caitlin R., Pantel, Klaus, Lu, Yong-Jie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10237083/ https://www.ncbi.nlm.nih.gov/pubmed/37268719 http://dx.doi.org/10.1038/s41571-023-00781-y

Ejemplares similares

Blood-Based Analysis of Circulating Cell-Free DNA and Tumor Cells for Early Cancer Detection
por: Pantel, Klaus
Publicado: (2016)

Clinical relevance and biology of circulating tumor cells
por: Bednarz-Knoll, Natalia, et al.
Publicado: (2011)

Biological Characterization and Clinical Relevance of Circulating Tumor Cells: Opening the Pandora’s Box of Multiple Myeloma
por: Garcés, Juan-José, et al.
Publicado: (2022)

Clinical Relevance of Circulating Tumor Cells in Esophageal Cancer Detected by a Combined MACS Enrichment Method
por: Woestemeier, Anna, et al.
Publicado: (2020)

Micrometastatic spread in breast cancer: detection, molecular characterization and clinical relevance
por: Fehm, Tanja, et al.
Publicado: (2008)

Biology, detection, and clinical implications of circulating tumor cells
por: Joosse, Simon A, et al.
Publicado: (2015)

Towards Increasing the Clinical Relevance of In Silico Methods to Predict Pathogenic Missense Variants
por: Masica, David L., et al.
Publicado: (2016)

Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
por: Keller, Laura, et al.
Publicado: (2020)

Electrochemical Biosensors for Circulating Tumor DNA Detection
por: Wang, Ke, et al.
Publicado: (2022)

Possible Role of Circulating Tumour Cells for Prediction of Salvage Lymph Node Dissection Outcome in Patients with Early Prostate Cancer Recurrence
por: Knipper, Sophie, et al.
Publicado: (2021)

Biology and clinical relevance of EpCAM
por: Keller, Laura, et al.
Publicado: (2019)

Circulating Tumor Cells: From the Laboratory to the Cancer Clinic
por: Agashe, Ruchi, et al.
Publicado: (2020)

Clinical relevance and current challenges of research on disseminating tumor cells in cancer patients
por: Riethdorf, Sabine, et al.
Publicado: (2009)

Building clinically relevant outcomes across the Alzheimer's disease spectrum
por: Rentz, Dorene M., et al.
Publicado: (2021)

Detection of clustered circulating tumour cells in early breast cancer
por: Krol, Ilona, et al.
Publicado: (2021)

Experimental encephalomyelitis at age 90, still relevant and elucidating how viruses trigger disease
por: Steinman, Lawrence, et al.
Publicado: (2023)

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer
por: Hanssen, Annkathrin, et al.
Publicado: (2015)

Functional analysis of circulating tumour cells: the KEY to understand the biology of the metastatic cascade
por: Eslami-S, Zahra, et al.
Publicado: (2022)

Circulating free DNA in the era of precision oncology: Pre- and post-analytical concerns
por: Lu, Jun-Liang, et al.
Publicado: (2016)

Emerging precision diagnostics in advanced cutaneous squamous cell carcinoma
por: Geidel, Glenn, et al.
Publicado: (2022)

The oncological relevance of fragile sites in cancer
por: Simpson, Benjamin S., et al.
Publicado: (2021)

Mining Methylation for Early Detection of Common Cancers
por: Brena, Romulo M, et al.
Publicado: (2006)

Clinical prospects of WRN inhibition as a treatment for MSI tumours
por: Morales-Juarez, David A., et al.
Publicado: (2022)

Biobanking in Molecular Biomarker Research for the Early Detection of Cancer
por: Lommen, Kim, et al.
Publicado: (2020)

Early detection of gastric cancer in China: progress and opportunities
por: Xu, Hengmin, et al.
Publicado: (2022)

Advances in liquid biopsy approaches for early detection and monitoring of cancer
por: Babayan, Anna, et al.
Publicado: (2018)

“Yes, but will it work for my patients?” Driving clinically relevant research with benchmark datasets
por: Panch, Trishan, et al.
Publicado: (2020)

Improving Translational Relevance in Preclinical Psychopharmacology (iTRIPP)
por: Bailey, Sarah J, et al.
Publicado: (2023)

Circulating DNA as biomarker in breast cancer
por: Schwarzenbach, Heidi, et al.
Publicado: (2015)

Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer
por: Jaworski, Jedrzej J., et al.
Publicado: (2020)

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as a Liquid Biopsy Marker in Colorectal Cancer
por: Heidrich, Isabel, et al.
Publicado: (2021)

Detection and Characterization of Circulating Tumor Cells Using Imaging Flow Cytometry—A Perspective Study
por: Muchlińska, Anna, et al.
Publicado: (2022)

Relevance relations for the concept of reproducibility
por: Atmanspacher, H., et al.
Publicado: (2014)

Animals, quality and the pursuit of relevance
por: Svenson, Karen L., et al.
Publicado: (2022)

Fungal Contaminants in Drinking Water Regulation? A Tale of Ecology, Exposure, Purification and Clinical Relevance
por: Novak Babič, Monika, et al.
Publicado: (2017)

Relevance of Pharmacogenomics to the Safe Use of Antimicrobials
por: Daly, Ann K.
Publicado: (2023)

TP53 mutations on circulating cell-free DNA
por: Pantel, Klaus
Publicado: (2016)

Innovation in observation: a vision for early outbreak detection
por: Fefferman, NH, et al.
Publicado: (2010)

Advances in circulating tumor cells (ACTC): from basic research to clinical practice
por: Lianidou, Evi S, et al.
Publicado: (2013)

Sputum smear microscopy in tuberculosis: Is it still relevant?
por: Desikan, Prabha
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_quc9mvto1uvo0aorsu5p8mrjpf